A double-blind randomised placebo-controlled trial of topical nasal steroids in 4-11 year old children with persistent bilateral otitis media with effusion in primary care
Phase of Trial: Phase III
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Mometasone (Primary)
- Indications Otitis media
- Focus Therapeutic Use
- Acronyms GNOME
- 22 Mar 2010 Results published in Value in Health.
- 22 Apr 2009 Planned number of patients changed from 388 to 400 and additional lead trial centre identified as reported by United Kingdom Clinical Research Network record.
- 22 Apr 2009 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network record.